Immunoglobulin Products

Online version of the Criteria

An adaptation of the second edition of the Criteria has been included in BloodSTAR and is applicable for all states and territories except NSW from 2016. The Criteria as they appear in BloodSTAR (version 2.1) can be viewed here.

The inclusion of new ‘evidence items’ fields within the Criteria version 2.1 in BloodSTAR does not change the basis for approval of authorisation of Ig product.

Information relating to access arrangements in relation to the supply of pooled normal human immunoglobulin products (administered intravenously, subcutaneously and intramuscularly), funded and supplied by all Australian governments under the national blood arrangements administered by the National Blood Authority.

For further information please contact the National Blood Authority on 13 000 IG GOV (13 000 44 468) or email support [at] blood.gov.au

Keep up to date

Keep up to date with the latest Immunoglobulin Governance updates - create a BloodPortal account and from the home page click on ‘My Subscriptions’ and ‘Subscribe’ to Immunoglobulin. The latest update is available at Ig Governance Criteria and Progress Updates.